CUHK Develops Microrobots To Speed Up Medical Test

"); jQuery("#212 h3").html("

Related News Programmes

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1442669_1_20190213182235.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1442669-20190213.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1442669-20190213.htm', 'DCS.dcsqry', '' ); } } }); }); });

2019-02-13 HKT 18:22

Share this story

facebook

  • Researchers say their new microrobots will drastically cut down the time it takes to check whether patients have a C difficile infection. Photo: RTHK

    Researchers say their new microrobots will drastically cut down the time it takes to check whether patients have a C difficile infection. Photo: RTHK

Experts at Chinese University have developed a new test using microscopic robots that they say can diagnose people suffering from a deadly type of gastrointestinal infection known as Clostridium Difficile, in a fraction of the time that current tests take.

C difficile infections are very common – especially among elderly patients and the chronically ill – and can prove fatal in extreme cases. Patients typically have symptoms such as diarrhoea and fever, and doctors need to identify whether patients are in fact infected with this particular type of bacteria before they can start treatment.

The problem is, patients have to undergo two sets of tests that can take as long as two days – a delay that doctors say is not ideal.

But experts at Chinese University say microrobots smaller than a red blood cell, made from plant spores, can cut that time down to 15 minutes.

The microrobots have carbon dots on them, that are fluorescent. But if they're mixed in with stool samples that contain toxins produced by C difficile, their fluorescence declines.

Professor Joseph Sung from the university's faculty of medicine said this new test isn't just quick, it is more accurate.

"The advantage of this test is that it can skip the two-step approach that we currently use for the diagnosis of C difficile diarrhoea," Sung said.

The Faculty of Engineering's Professor Zhang Li, who developed the microrobots, said they could be used to identify other pathogens in future.

The university said it will conduct more clinical trials this year before deciding when to officially introduce the new test.

RECENT NEWS

HashKey Gets Regulatory Nod To Offer Virtual Asset Services In Ireland

HashKey Group has announced that its subsidiary, HashKey Europe Limited, has received Virtual Asset Service Provider (V... Read more

HKVAX And Victory Securities Forge Partnership To Advance Hong Kongs Virtual Asset Ecosystem

Hong Kong Virtual Asset Exchange (HKVAX), Hong Kong’s third virtual asset licensed trading platform and Victory Secur... Read more

5 Major Banks Mantain Domestic Systemically Important Authorised Institutions Status

The Hong Kong Monetary Authority (HKMA) concluded its annual review of Domestic Systemically Important Authorised Insti... Read more

HSBC, StanChart, Alibaba Cloud Among First Cohort Of HKMAs Gen AI Sandbox

The Hong Kong Monetary Authority (HKMA) and Cyberport have announced the first cohort of its Generative Artificial Inte... Read more

QuickFest 2025 To Focus On AI, Automation, And The Future Of Accounting

QuickFest, the virtual conference tailored for accounting professionals, bookkeepers, and consultants, will return on 1... Read more

5 Stories That Shaped Hong Kongs Fintech Scene In 2024

In 2024, Hong Kong further cemented its position as a leading fintech hub in the world, with the number of fintech comp... Read more